InterCure Ltd. — Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd., an Israeli foreign private issuer, filed this Form 6-K on July 24, 2023, covering the month of July 2023. The filing is an exhibit submission rather than a quarterly or annual financial report.
The filing identifies InterCure’s principal executive offices in Herzliya, Israel, and confirms that the company files annual reports on Form 20-F.
Filed Materials and Key Financial Information
- Exhibit 99.1: Management Information Circular.
- Exhibit 99.2: Form of Proxy.
- The provided filing text does not include revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating metrics.
Material Changes, Outlook, and Risks
The provided Form 6-K text does not describe material changes versus a prior period, management outlook, contingencies, unusual items, or specific business risks. These matters may be addressed in the attached management information circular, which is not included in the provided text.
Important Facts to Verify
- Review the management information circular for the transaction, meeting matters, proposed resolutions, and related disclosures.
- Review the proxy form for voting procedures, deadlines, and shareholder actions.
- Confirm whether the exhibits contain financial information, risk factors, related-party matters, or material corporate actions not summarized in the Form 6-K cover page.
- Verify the applicable shareholder meeting date and record date from the exhibits.